Henry Dunant Hospital

Athens 11526

0 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Early Breast Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis — Completed